Community-associated Methicillin-resistant Staphylococcus Aureus: Incidence, Clinical Presentation, and Treatment Decisions

Overview

Journal Curr Infect Dis Rep

Specialty Infectious Diseases

Date 2007 Sep 21

PMID 17880850

Citations 3

Authors

Fredrick M Abrahamian

Eric W Snyder

Affiliations

Soon will be listed here.

Abstract

Community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA) infections have been reported with increasing frequency from many parts of the world. Most infections involve the skin and soft tissue structures, and CA-MRSA is now the most commonly identifiable cause of purulent skin and soft tissue infections. The spectrum of disease can range from simple cutaneous abscesses to fulminant necrotizing infection. CA-MRSA strains, in contrast to healthcare-associated strains, are generally extra virulent and produce more toxins. Unlike the healthcare-associated strains, they demonstrate variable susceptibility patterns to various classes of antibiotics. Empiric antibiotic therapy for patients with purulent skin and soft tissue infection and for those presenting with severe, life-threatening infections should include an agent active against CA-MRSA.

Citing Articles

Polymeric Forms of Plant Flavonoids Obtained by Enzymatic Reactions.

Latos-Brozio M, Masek A, Piotrowska M Molecules. 2022; 27(12).

PMID: 35744827 PMC: 9228980. DOI: 10.3390/molecules27123702.

Community-associated methicillin-resistant infection: Literature review and clinical update.

Loewen K, Schreiber Y, Kirlew M, Bocking N, Kelly L Can Fam Physician. 2017; 63(7):512-520.

PMID: 28701438 PMC: 5507223.

Incidence, characteristics, and outcomes of patients with bone and joint infections due to community-associated methicillin-resistant Staphylococcus aureus: a systematic review.

Vardakas K, Kontopidis I, Gkegkes I, Rafailidis P, Falagas M Eur J Clin Microbiol Infect Dis. 2013; 32(6):711-21.

PMID: 23334662 DOI: 10.1007/s10096-012-1807-3.

References

Harbarth S, Dharan S, Liassine N, Herrault P, Auckenthaler R, Pittet D . Randomized, placebo-controlled, double-blind trial to evaluate the efficacy of mupirocin for eradicating carriage of methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother. 1999; 43(6):1412-6. PMC: 89288. DOI: 10.1128/AAC.43.6.1412. View

Weigelt J, Itani K, Stevens D, Lau W, Dryden M, Knirsch C . Linezolid versus vancomycin in treatment of complicated skin and soft tissue infections. Antimicrob Agents Chemother. 2005; 49(6):2260-6. PMC: 1140485. DOI: 10.1128/AAC.49.6.2260-2266.2005. View

Herold B, Immergluck L, Maranan M, Lauderdale D, Gaskin R, Leitch C . Community-acquired methicillin-resistant Staphylococcus aureus in children with no identified predisposing risk. JAMA. 1998; 279(8):593-8. DOI: 10.1001/jama.279.8.593. View

Squire B, Fox J, Anderson C . ABSCESS: applied bedside sonography for convenient evaluation of superficial soft tissue infections. Acad Emerg Med. 2005; 12(7):601-6. DOI: 10.1197/j.aem.2005.01.016. View

Kampf G, Jarosch R, Ruden H . Limited effectiveness of chlorhexidine based hand disinfectants against methicillin-resistant Staphylococcus aureus (MRSA). J Hosp Infect. 1998; 38(4):297-303. DOI: 10.1016/s0195-6701(98)90078-0. View

Lina G, Piemont Y, Bes M, Peter M, Gauduchon V, Vandenesch F . Involvement of Panton-Valentine leukocidin-producing Staphylococcus aureus in primary skin infections and pneumonia. Clin Infect Dis. 1999; 29(5):1128-32. DOI: 10.1086/313461. View

Gillet Y, Issartel B, Vanhems P, Fournet J, Lina G, Bes M . Association between Staphylococcus aureus strains carrying gene for Panton-Valentine leukocidin and highly lethal necrotising pneumonia in young immunocompetent patients. Lancet. 2002; 359(9308):753-9. DOI: 10.1016/S0140-6736(02)07877-7. View

Miller L, Quan C, Shay A, Mostafaie K, Bharadwa K, Tan N . A prospective investigation of outcomes after hospital discharge for endemic, community-acquired methicillin-resistant and -susceptible Staphylococcus aureus skin infection. Clin Infect Dis. 2007; 44(4):483-92. DOI: 10.1086/511041. View

Yu V, Goetz A, Wagener M, Smith P, Rihs J, Hanchett J . Staphylococcus aureus nasal carriage and infection in patients on hemodialysis. Efficacy of antibiotic prophylaxis. N Engl J Med. 1986; 315(2):91-6. DOI: 10.1056/NEJM198607103150204. View

10.

Tayal V, Hasan N, Norton H, Tomaszewski C . The effect of soft-tissue ultrasound on the management of cellulitis in the emergency department. Acad Emerg Med. 2006; 13(4):384-8. DOI: 10.1197/j.aem.2005.11.074. View

11.

Diep B, Gill S, Chang R, Phan T, Chen J, Davidson M . Complete genome sequence of USA300, an epidemic clone of community-acquired meticillin-resistant Staphylococcus aureus. Lancet. 2006; 367(9512):731-9. DOI: 10.1016/S0140-6736(06)68231-7. View

12.

Siberry G, Tekle T, Carroll K, Dick J . Failure of clindamycin treatment of methicillin-resistant Staphylococcus aureus expressing inducible clindamycin resistance in vitro. Clin Infect Dis. 2003; 37(9):1257-60. DOI: 10.1086/377501. View

13.

Kazakova S, Hageman J, Matava M, Srinivasan A, Phelan L, Garfinkel B . A clone of methicillin-resistant Staphylococcus aureus among professional football players. N Engl J Med. 2005; 352(5):468-75. DOI: 10.1056/NEJMoa042859. View

14.

Naimi T, LeDell K, Como-Sabetti K, Borchardt S, Boxrud D, Etienne J . Comparison of community- and health care-associated methicillin-resistant Staphylococcus aureus infection. JAMA. 2003; 290(22):2976-84. DOI: 10.1001/jama.290.22.2976. View

15.

Kuehnert M, Kruszon-Moran D, Hill H, McQuillan G, McAllister S, Fosheim G . Prevalence of Staphylococcus aureus nasal colonization in the United States, 2001-2002. J Infect Dis. 2005; 193(2):172-9. DOI: 10.1086/499632. View

16.

Simor A, Phillips E, McGeer A, Konvalinka A, Loeb M, Devlin H . Randomized controlled trial of chlorhexidine gluconate for washing, intranasal mupirocin, and rifampin and doxycycline versus no treatment for the eradication of methicillin-resistant Staphylococcus aureus colonization. Clin Infect Dis. 2006; 44(2):178-85. DOI: 10.1086/510392. View

17.

. Four pediatric deaths from community-acquired methicillin-resistant Staphylococcus aureus — Minnesota and North Dakota, 1997-1999. MMWR Morb Mortal Wkly Rep. 2010; 48(32):707-10. View

18.

Moran G, Amii R, Abrahamian F, Talan D . Methicillin-resistant Staphylococcus aureus in community-acquired skin infections. Emerg Infect Dis. 2005; 11(6):928-30. PMC: 3367577. DOI: 10.3201/eid1106.040641. View

19.

Ellis M, Hospenthal D, Dooley D, Gray P, Murray C . Natural history of community-acquired methicillin-resistant Staphylococcus aureus colonization and infection in soldiers. Clin Infect Dis. 2004; 39(7):971-9. DOI: 10.1086/423965. View

20.

Drew R, Perfect J, Srinath L, Kurkimilis E, Dowzicky M, Talbot G . Treatment of methicillin-resistant staphylococcus aureus infections with quinupristin-dalfopristin in patients intolerant of or failing prior therapy. For the Synercid Emergency-Use Study Group. J Antimicrob Chemother. 2000; 46(5):775-84. DOI: 10.1093/jac/46.5.775. View